The primary enforcement concerns have centered on marketing claims that imply equivalence to FDA-approved products and branding practices that obscure the identity of the actual compounder
Titration governs tolerability fast 2-week ramp to 15 mg gave 24.5% AE-discontinuation (Frias 2018)
It's one of the first questions patients ask their providers, and honestly, it's the right question to ask
Furthermore, close to half (49%) of current GLP-users cited moderate to severe medication side effects this month, but cost is still a greater deterrent for medication usage
When weight loss occurs, the body undergoes metabolic adaptations including decreased energy expenditure, increased hunger hormones (such as ghrelin), and reduced satiety signals
123 Following promising preclinical findings, several clinical trials have been initiated to evaluate the neuroprotective efficacy of GLP-1RAs in diverse populations, including individuals with diabetes, those at risk of cognitive decline, and patients diagnosed with AD or PD
